437 related articles for article (PubMed ID: 25825481)
1. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
Rebholz CM; Grams ME; Matsushita K; Inker LA; Foster MC; Levey AS; Selvin E; Coresh J
Clin J Am Soc Nephrol; 2015 Jun; 10(6):941-8. PubMed ID: 25825481
[TBL] [Abstract][Full Text] [Related]
2. Change in novel filtration markers and risk of ESRD.
Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
[TBL] [Abstract][Full Text] [Related]
3. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
[TBL] [Abstract][Full Text] [Related]
4. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C-based glomerular filtration rate associates more closely with mortality than creatinine-based or combined glomerular filtration rate equations in unselected patients.
Helmersson-Karlqvist J; Ärnlöv J; Larsson A
Eur J Prev Cardiol; 2016 Oct; 23(15):1649-57. PubMed ID: 27037092
[TBL] [Abstract][Full Text] [Related]
6. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.
van der Velde M; Matsushita K; Coresh J; Astor BC; Woodward M; Levey A; de Jong P; Gansevoort RT; ; van der Velde M; Matsushita K; Coresh J; Astor BC; Woodward M; Levey AS; de Jong PE; Gansevoort RT; Levey A; El-Nahas M; Eckardt KU; Kasiske BL; Ninomiya T; Chalmers J; Macmahon S; Tonelli M; Hemmelgarn B; Sacks F; Curhan G; Collins AJ; Li S; Chen SC; Hawaii Cohort KP; Lee BJ; Ishani A; Neaton J; Svendsen K; Mann JF; Yusuf S; Teo KK; Gao P; Nelson RG; Knowler WC; Bilo HJ; Joosten H; Kleefstra N; Groenier KH; Auguste P; Veldhuis K; Wang Y; Camarata L; Thomas B; Manley T
Kidney Int; 2011 Jun; 79(12):1341-52. PubMed ID: 21307840
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of β2-microglobulin and cystatin C are associated with left atrial size: additional link between the kidney and the heart.
Liu YS; Wang X; Jiang WD; Huang ZW; Wang YM; Hao L; Xing JL; Wang L; Liu XX; Lounsbury P; Zhang M; Lu QH
Clin Nephrol; 2013 Sep; 80(3):168-76. PubMed ID: 23849305
[TBL] [Abstract][Full Text] [Related]
8. Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes.
Waheed S; Matsushita K; Astor BC; Hoogeveen RC; Ballantyne C; Coresh J
Clin J Am Soc Nephrol; 2013 Mar; 8(3):434-42. PubMed ID: 23258794
[TBL] [Abstract][Full Text] [Related]
9. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
10. Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
Deo R; Fyr CL; Fried LF; Newman AB; Harris TB; Angleman S; Green C; Kritchevsky SB; Chertow GM; Cummings SR; Shlipak MG;
Am Heart J; 2008 Jan; 155(1):62-8. PubMed ID: 18082491
[TBL] [Abstract][Full Text] [Related]
11. Cystatin C and sudden cardiac death risk in the elderly.
Deo R; Sotoodehnia N; Katz R; Sarnak MJ; Fried LF; Chonchol M; Kestenbaum B; Psaty BM; Siscovick DS; Shlipak MG
Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):159-64. PubMed ID: 20233980
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C and the risk of death and cardiovascular events among elderly persons.
Shlipak MG; Sarnak MJ; Katz R; Fried LF; Seliger SL; Newman AB; Siscovick DS; Stehman-Breen C
N Engl J Med; 2005 May; 352(20):2049-60. PubMed ID: 15901858
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C and creatinine as markers of bleeding complications, cardiovascular events and mortality during oral anticoagulant treatment.
Lind M; Jansson JH; Nilsson TK; Järvholm LS; Johansson L
Thromb Res; 2013 Aug; 132(2):e77-82. PubMed ID: 23834818
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
[TBL] [Abstract][Full Text] [Related]
15. Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.
Foster MC; Inker LA; Levey AS; Selvin E; Eckfeldt J; Juraschek SP; Coresh J;
Am J Kidney Dis; 2013 Jul; 62(1):42-51. PubMed ID: 23518194
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism.
Kostrubiec M; Łabyk A; Pedowska-Włoszek J; Dzikowska-Diduch O; Wojciechowski A; Garlińska M; Ciurzyński M; Pruszczyk P
Heart; 2012 Aug; 98(16):1221-8. PubMed ID: 22705926
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis.
Hoke M; Amighi J; Mlekusch W; Schlager O; Exner M; Sabeti S; Dick P; Koppensteiner R; Minar E; Rumpold H; Wagner O; Schillinger M
Stroke; 2010 Apr; 41(4):674-9. PubMed ID: 20150544
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of kidney function and prediction of death from cardiovascular and other causes in the elderly: A 9-year follow-up study.
Salminen M; Laine K; Korhonen P; Wasen E; Vahlberg T; Isoaho R; Kivelä SL; Löppönen M; Irjala K
Eur J Intern Med; 2016 Sep; 33():98-101. PubMed ID: 27370901
[TBL] [Abstract][Full Text] [Related]
19. Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.
Tomaschitz A; Pilz S; Ritz E; Grammer T; Drechsler C; Boehm BO; März W
Am J Kidney Dis; 2011 Mar; 57(3):403-14. PubMed ID: 21186074
[TBL] [Abstract][Full Text] [Related]
20. Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.
Schei J; Stefansson VT; Mathisen UD; Eriksen BO; Solbu MD; Jenssen TG; Melsom T
Clin J Am Soc Nephrol; 2016 Feb; 11(2):280-6. PubMed ID: 26668020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
